Therapeutic Solutions Granted Patent on Available QuadraMune Nutraceutical
Therapeutic Solutions Announces Finding Regarding MOA of its JadiCell Product
Therapeutic Solutions International Files Patent on “Facilitating Effects” of JadiCells on Gene Therapy Mediated Cell Differentiation
Therapeutic Solutions International Files Lawsuit in San Diego Superior Court to Obtain Identities of Certain Individuals or Entities
Therapeutic Solutions Launches Adult Stem Cell Therapy Company
Res Nova Announces Positive Data on Cancer Patients Treated with FloraStilbene™
Therapeutic Solutions International Announces Formation of ALS Biologics Inc
Therapeutic Solutions International and Campbell Neurosciences Publish on Nutritional Modulation of the Indolamine 2,3 Dioxygenase Pathway as a Non-Toxic Means of Addressing Depression
ELK CITY, Idaho--(BUSINESS WIRE)--Therapeutic Solutions International, Inc. (TSOI), announced today the publication of a peer-reviewed paper entitled “Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccines” which appeared in the November 2023 issue of the Journal of Translational Medicine1. The article was co-authored by Therapeutic Solutions International Board Member Dr. Thomas Ichim, Chief Scientific Officer Dr. Feng Lin, and Scientific Advisory Board Members Drs Santosh Kesari and Francesco Marincola.
Therapeutic Solutions International Reports Landmark Advancement in Stem Cell Therapy of Frontotemporal Dementia